SCHEMBL7708528

SCHEMBL7708528

Nc1c(-c2ccncc2)ccn2nc(-c3ccccc3)nc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.49
PARP1 P09874 1/20 0.46
DHODH Q02127 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.40
ADORA2A P29274 1/20 0.40
ADORA1 P30542 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
HTT P42858 1/20 0.40
AHR P35869 1/20 0.38
KDR P35968 1/20 0.38
NOTUM Q6P988 1/20 0.38
RET P07949 1/20 0.38
PIK3CD O00329 1/20 0.38
PIK3CB P42338 1/20 0.38
PIK3CG P48736 1/20 0.38
IKBKB O14920 1/20 0.37
CHUK O15111 1/20 0.37
IKBKE Q14164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19327473 0.71 PARP1 (0.61) JAK2PARP1DHODHADORA2AADORA1
SCHEMBL9107632 0.71 PARP1 (0.50) PARP1DHODHADORA2AADORA1ALDH1A1
SCHEMBL7708883 0.70 PDE10A (0.56) DHODHSMN1; SMN2MAPTAHRKDR
SCHEMBL11416817 0.68 DHODH (0.50) PARP1DHODHSMN1; SMN2ADORA1ALDH1A1
SCHEMBL14822647 0.68 JAK2 (0.50) JAK2PARP1DHODHSMN1; SMN2ALDH1A1
SCHEMBL11475282 0.66 CYP11B2 (0.53) JAK2DHODHSMN1; SMN2ADORA2AADORA1
SCHEMBL15173442 0.66 AHR (0.78) PARP1DHODHSMN1; SMN2ADORA1MAPT
SCHEMBL11262382 0.66 DHODH (0.55) PARP1DHODHSMN1; SMN2ADORA1MAPT
SCHEMBL30590678 0.66 JAK2 (0.48) JAK2PARP1ADORA2AADORA1AHR
SCHEMBL2640477 0.66 JAK2 (1.00) JAK2ADORA2AADORA1PIK3CDPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 US disclosed